The Food and Drug Administration rule says over-the-counter consumer antiseptic wash products with one or more of 19 specific active ingredients — including triclosan — can no longer be marketed, according to an article on the Infection Control & Clinical Quality website.
The FDA said soap manufacturers did not demonstrate that the ingredients are both safe for long-term daily use and more effective than plain soap and water.
Manufacturers did not provide necessary data for 19 affected ingredients, which are now banned. They include triclocarban and triclosan.
When the proposed rule was released in 2013, some manufacturers started taking some products containing the banned active ingredients off the market. Now, they will have one year to comply with the final rule.
Resilience Planning in Remote Healthcare Facilities
Missouri Southern State University Opens Roy Blunt Health Science Innovation Center
HCA Florida Unveils Plans for New Cape Coral Hospital
5 Reasons Engineering is the Edge in Healthcare Master Planning
Building an AI-Ready Healthcare Facility